So-called "Magnificent Seven" stocks Amazon, Meta Platforms, and Nvidia remain great long-term picks. The Trade Desk's share ...

Gilead (GILD) stock and Vertex Pharma (VRTX) stock are said to be relatively immune to Trump administration's tariffs threats ...

The stock's fall snapped a seven-day winning streak.

VRTX has recorded a positive one-day return after earnings in 58% of instances. When the return is positive, the median ...

The European Medicines Agency has recommended marketing approval for Alyftrek for cystic fibrosis and Attrogy for a form of ...

FOX Sports' Joel Klatt joins Colin Cowherd to dive into what led to Shedeur Sanders dropping to the fifth round and how he ...

Baron Health Care Fund retreated in the first quarter of 2025, underperforming its benchmark, the Russell 3000 Health Care ...

Analysts anticipate Vertex Pharmaceuticals to report an earnings per share (EPS) of $4.31. Anticipation surrounds Vertex Pharmaceuticals's announcement, with investors hoping to hear about both ...

Amid a reckoning for the gene therapy field, Vertex Pharmaceuticals has joined a growing list of companies paring back their ...

Shares of Vertex Pharmaceuticals Inc. VRTX rallied 1.19% to $509.50 Wednesday, on what proved to be an all-around positive ...

The new campaign stars former NFL quarterback Alex Smith, whose leg injury during a 2018 game led to a case of life-threatening necrotizing fasciitis, sepsis and 17 surgeries. Though amputation was ...

Vertex (VRTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.